GeoVax Labs, Inc. revenue breakdown overview

GeoVax Labs, Inc. revenue for the last year amounted to 3.96 M USD, the most of which — 3.95 M USD — came from its highest performing source at the moment, Vaccines and Immunotherapies, the year earlier bringing 81.53 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought GeoVax Labs, Inc. 3.95 M USD, and the year before that — 81.53 k USD.